Amneal Pharmaceuticals Q3 Adj. EPS $0.26 Beats $0.23 Estimate, Sales $862.684M Beat $816.058M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Amneal Pharmaceuticals (NASDAQ:AMRX) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.23 by 13.04 percent. This is a 52.94 percent increase over earnings of $0.17 per share
Amneal Pharmaceuticals (NASDAQ:AMRX) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.23 by 13.04 percent. This is a 52.94 percent increase over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $862.684 million which beat the analyst consensus estimate of $816.058 million by 5.71 percent. This is a 9.96 percent increase over sales of $784.513 million the same period last year.